CSIR-CCMB builds India-specific severity score for sickle cell anaemia from Indian children’s data

The news

Hyderabad. Scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB) have developed an India-specific score to predict how severely sickle cell anaemia (SCA) will affect a patient, The Hindu reports. SCA is an inherited blood disorder in which a mutation in the beta globin gene produces abnormal haemoglobin, making red blood cells take a sickle shape; the result is anaemia, severe pain episodes and organ damage. Existing international scoring systems do not reflect Indian patients, who are said to have a milder disease than many African populations. The first model, ISS1 (India-specific Severity Score), built from clinical data on Indian children, improved clinical assessments to nearly 83%. A second, ISS2, replaces laboratory measurements with easily observable clinical signs and reaches about 85% agreement. India is among the countries with the highest burden, says Giriraj R. Chandak, who led the team.

Static syllabus linkage

1. Sickle cell disease is autosomal recessive, so carriers are healthy but pass the gene on. Inheriting the sickle gene from both parents causes the disease; inheriting it from one gives sickle cell trait, a usually healthy carrier. Two carriers face a one-in-four chance in each pregnancy of an affected child, which is why carrier screening and counselling are central to prevention. The Rights of Persons with Disabilities Act, 2016 lists sickle cell disease, with thalassaemia and haemophilia, among blood disorders counted as specified disabilities.
2. The national mission aims to eliminate sickle cell disease as a public health problem by 2047. The National Sickle Cell Anaemia Elimination Mission was launched in July 2023 at Shahdol, Madhya Pradesh. Run through the National Health Mission with a focus on tribal areas, it screens people up to 40 years of age, issues cards showing sickle status, and offers counselling and treatment.

Why UPSC loves this

1. The story joins two syllabus lines: health services and indigenous science. GS2 covers “issues relating to development and management of Social Sector/Services relating to Health”, and GS3 “achievements of Indians in science and technology; indigenization of technology”. This tool is a ready example for both.

Analysis

1. Lens — Growth and equity: a score that needs no laboratory reaches the patients the mission is for. The disease is concentrated in tribal districts, where a primary health centre may lack the laboratory to run the tests a standard severity score needs. ISS2, relying on signs a doctor can see, can be used where the patients actually are. So the simpler tool is the more equitable one, provided laboratory referral remains available when the score is uncertain.
2. Screening finds patients; a severity score decides who needs care first. Mass screening produces long lists of positives, and a system short of specialists must decide whom to follow closely. A reliable severity score turns that list into a priority list, the missing link between screening and treatment.
3. A score built on children must be tested before it guides care for all. The model rests on data from Indian children, and patients vary by region and age. Before entering national guidelines it needs validation in adults and other States, and a check that the idea of a ‘milder’ Indian disease does not cause undertreatment of severe patients. The counter-view is that waiting for perfect validation leaves clinicians using foreign scores known to fit badly.

Administrator's brainstorm